-
1 Comment
Getein Biotech, Inc is currently in a long term downtrend where the price is trading 33.8% below its 200 day moving average.
From a valuation standpoint, the stock is 16.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.0.
Getein Biotech, Inc's total revenue rose by 13.4% to $383M since the same quarter in the previous year.
Its net income has dropped by 28.1% to $101M since the same quarter in the previous year.
Finally, its free cash flow fell by 28.9% to $72M since the same quarter in the previous year.
Based on the above factors, Getein Biotech, Inc gets an overall score of 2/5.
Exchange | SHG |
---|---|
CurrencyCode | CNY |
ISIN | CNE100002RR9 |
Sector | Healthcare |
Industry | Medical Devices |
Market Cap | 4B |
---|---|
PE Ratio | 15.94 |
Target Price | 37.4 |
Beta | 0.34 |
Dividend Yield | None |
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection of cardiac troponin I, chemiluminescence, biochemical detection, molecular detection, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, thrombosis and hemostasis, and other technical fields, covering cardiovascular, inflammation, kidney, thyroid function, hormone, glucose metabolism, tumor, blood cells, blood coagulation, and other detection fields. Its product applications include laboratory departments of medical institutions, emergency rooms, health examination center, community clinic, family personal health management, etc. The company was founded in 2002 and is headquartered in Nanjing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 603387.SHG using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025